← Evidence map

ArticleCell reports. Medicine2021

What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?

Jens Juul HolstPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34095885